Tech Company Financing Transactions

Omada Health Funding Round

Omada Health closed a $73 million funding round on 6/27/2019. Investors included Wellington Management Company, Andreessen Horowitz and Cigna.

Transaction Overview

Company Name
Omada Health
Announced On
6/27/2019
Transaction Type
Venture Equity
Amount
$73,000,000
Round
Undisclosed
Investors

Wellington Management Company (Lead Investor)

Andreessen Horowitz (Vijay Pande)

Cigna (Joan Harvey)

Civilization Ventures

Kaiser Permanente Ventures

Norwest Venture Partners (Casper de Clercq)

Providence Ventures

Sanofi-Genzyme BioVentures

U.S. Venture Partners (Jon Root)

Proceeds Purpose
Omada will use the funding to fuel the continued expansion of its digital care program, including support for those with type 2 diabetes and hypertension, as well as those dealing with anxiety and depression.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
500 Sansome St. 200
San Francisco, CA 94111
USA
Phone
(888) 987-8337
Website
www.omadahealth.com
Email Address
[email protected]
Overview
Since 2011, Omada has been an industry leader in virtual care, building care programs that people don't just try, but stick with. We've gained worldwide recognition for evidence-based solutions that help people manage chronic conditions and live healthier lives.
Profile
Omada Health LinkedIn Company Profile
Social Media
Omada Health Company Twitter Account
Company News
Omada Health News
Facebook
Omada Health on Facebook
YouTube
Omada Health on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Sean Duffy
  Sean Duffy LinkedIn Profile  Sean Duffy Twitter Account  Sean Duffy News  Sean Duffy on Facebook
Chief Financial Officer
Sarah Blanchard
  Sarah Blanchard LinkedIn Profile  Sarah Blanchard Twitter Account  Sarah Blanchard News  Sarah Blanchard on Facebook
Chief Financial Officer
Steve Cook
  Steve Cook LinkedIn Profile  Steve Cook Twitter Account  Steve Cook News  Steve Cook on Facebook
Chief Information Officer
William Dougherty
  William Dougherty LinkedIn Profile  William Dougherty Twitter Account  William Dougherty News  William Dougherty on Facebook
Chief Medical Officer
Carolyn Jasik
  Carolyn Jasik LinkedIn Profile  Carolyn Jasik Twitter Account  Carolyn Jasik News  Carolyn Jasik on Facebook
Chief Technical Officer
Sunil Kayiti
  Sunil Kayiti LinkedIn Profile  Sunil Kayiti Twitter Account  Sunil Kayiti News  Sunil Kayiti on Facebook
President
Adrian James
  Adrian James LinkedIn Profile  Adrian James Twitter Account  Adrian James News  Adrian James on Facebook
VP - Bus. Development
Wei-Li Shao
  Wei-Li Shao LinkedIn Profile  Wei-Li Shao Twitter Account  Wei-Li Shao News  Wei-Li Shao on Facebook
VP - Engineering
Maria Latushkin
  Maria Latushkin LinkedIn Profile  Maria Latushkin Twitter Account  Maria Latushkin News  Maria Latushkin on Facebook
VP - General Counsel
Justin Ferber
  Justin Ferber LinkedIn Profile  Justin Ferber Twitter Account  Justin Ferber News  Justin Ferber on Facebook
VP - General Counsel
Nathan Salha
  Nathan Salha LinkedIn Profile  Nathan Salha Twitter Account  Nathan Salha News  Nathan Salha on Facebook
VP - Marketing
Anurag Wadehra
  Anurag Wadehra LinkedIn Profile  Anurag Wadehra Twitter Account  Anurag Wadehra News  Anurag Wadehra on Facebook
VP - Operations
Chris Sharon
  Chris Sharon LinkedIn Profile  Chris Sharon Twitter Account  Chris Sharon News  Chris Sharon on Facebook
VP - Product Management
Michael Tadlock
  Michael Tadlock LinkedIn Profile  Michael Tadlock Twitter Account  Michael Tadlock News  Michael Tadlock on Facebook
VP - Product Management
Randhir Vieira
  Randhir Vieira LinkedIn Profile  Randhir Vieira Twitter Account  Randhir Vieira News  Randhir Vieira on Facebook
VP - Regulatory Affairs
Lucia Savage
  Lucia Savage LinkedIn Profile  Lucia Savage Twitter Account  Lucia Savage News  Lucia Savage on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/27/2019: TissueTech venture capital transaction
Next: 6/27/2019: Join venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.